Erik C. B. Johnson
Erik C. B. Johnson publishes mostly in Physiology, Molecular Biology and Psychiatry and Mental health, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Bioinformatics and Genomic Networks.
- World rank
- #32,861 of 7,710,434 ranked researchers
- Rank in United States
- #12,499 of 1,627,098
- Works
- 132
- Citations
- 7k
- Citations per work
- 53.3
What does Erik C. B. Johnson research?
Erik C. B. Johnson's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (20%), Chemistry (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5541.3%
- Medicine5541.3%
- Everything else3828.5%
- Life Sciences3324.8%
- Physical Sciences75.4%
- Chemistry75.4%
- 1Physiology24% of their works
- 2Molecular Biology20% of their works
- 3Psychiatry and Mental health12% of their works
- 4Neurology6% of their works
- 5Spectroscopy5% of their works
- 6Biological Psychiatry5% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Bioinformatics and Genomic Networks
- Metabolomics and Mass Spectrometry Studies
- Advanced Proteomics Techniques and Applications
- Tryptophan and brain disorders
- Neuroinflammation and Neurodegeneration Mechanisms
- Chemical Synthesis and Analysis
Which keywords describe Erik C. B. Johnson's research?
The keywords of their largest research topics: Neuroinflammation, Oxidative Stress, Neurodegeneration, Amyloid Hypothesis, Tau Pathology, Biomarkers, Alzheimer's Disease and Mild Cognitive Impairment.
- Drug Discovery
- Astrocytes
- Depression
- Proteomics
- Metabolomics
- Data Analysis
- Cytokines
- Mild Cognitive Impairment
- Biomarkers
- Amyloid Hypothesis
- Oxidative Stress
- Neuroinflammation
- Neurodegeneration
- Tau Pathology
- Alzheimer's Disease
- Mass Spectrometry
- Microglia
- Gene Set Enrichment Analysis
- Protein-Protein Interaction Networks
- Quantitative Analysis
- Tryptophan Metabolism
- Synaptic Pruning
- Peptide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Neuroinflammation1103 topics
- Oxidative Stress982 topics
- Neurodegeneration942 topics
- Amyloid Hypothesis821 topic
- Tau Pathology821 topic
- Biomarkers582 topics
- Alzheimer's Disease401 topic
- Mild Cognitive Impairment401 topic
- Mass Spectrometry362 topics
- Cytokines282 topics
- Microglia282 topics
- Data Analysis181 topic
- Gene Set Enrichment Analysis181 topic
- Metabolomics181 topic
- Protein-Protein Interaction Networks181 topic
- Proteomics181 topic
- Quantitative Analysis181 topic
- Depression161 topic
- Tryptophan Metabolism161 topic
- Astrocytes121 topic
- Synaptic Pruning121 topic
- Drug Discovery81 topic
- Peptide Synthesis81 topic
Where does Erik C. B. Johnson work?
Erik C. B. Johnson's main affiliation in the publication record is Emory University, United States.
How many publications and citations does Erik C. B. Johnson have?
OpenAlex counts 132 works and 7,035 citations for Erik C. B. Johnson, an h-index of 39, ranking #32,861 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Erik C. B. Johnson
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Erik C. B. Johnson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.